Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies
Crossref DOI link: https://doi.org/10.1007/s40265-014-0305-6
Published Online: 2014-10-25
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shih, Kent
Arkenau, Hendrik-Tobias
Infante, Jeffrey R.
License valid from 2014-10-25